Yarrow Bioscience (YARW) Operating Margin (QoQ) (2017 - 2026)
Powered by 
Analysis
Yarrow Bioscience (YARW) Operating Margin (QoQ) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Yarrow Bioscience | 25.25 Mn | 2.33 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 71,400.00 |
| Jun 30, 2025 | -298,903.00 |
| Mar 31, 2025 | 1.06 Mn |
| Dec 31, 2024 | -438,337.00 |
| Sep 30, 2024 | -562,101.00 |
| Jun 30, 2024 | 218,200.00 |
| Mar 31, 2024 | 160,947.00 |
| Dec 31, 2023 | -352,105.00 |
| Sep 30, 2023 | 217,454.00 |
| Jun 30, 2023 | -176,796.00 |
| Mar 31, 2023 | 2.17 Mn |
| Dec 31, 2022 | -2.19 Mn |
| Sep 30, 2022 | 98,836.00 |
| Jun 30, 2022 | -169,440.00 |
| Mar 31, 2022 | -164,229.00 |
| Dec 31, 2021 | 485,520.00 |
| Sep 30, 2021 | -486,091.00 |
| Jun 30, 2021 | 100,760.00 |
| Mar 31, 2021 | -372,913.00 |
| Dec 31, 2020 | 20,556.00 |